Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Citius Pharmaceuticals (CTXR)
NASDAQ:CTXR
RESEARCH TOOLSreports
Citius Pharmaceuticals (CTXR) Stock Forecast & Price Target
1,171 Followers
See the Price Targets and Ratings of:
CTXR Analyst Ratings
Currently, no data available
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CTXR Stock 12 Months Forecast
There Are No Analyst Ratings for CTXR In The Last 3 Months.
| Highest Price Target― | Average Price Target― | Lowest Price Target― |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
CTXR Financial Forecast
Detailed List of Analyst Forecasts
H.C. Wainwright
$4.00
Buy
417.46%
Upside
Reiterated
08/10/23
Analysts Are Bullish on These Healthcare Stocks: Citius Pharmaceuticals (CTXR), Aprea Therapeutics (APRE)
Maxim Group
$4.00
Buy
417.46%
Upside
Assigned
06/26/23
Analysts Offer Insights on Healthcare Companies: Citius Pharmaceuticals (CTXR) and Abcam (ABCM) - TipRanks.comMaxim Group analyst Michael Okunewitch maintained a Buy rating on Citius Pharmaceuticals yesterday and set a price target of $4.00 . The companys shares closed last Friday at $1.29.
Dawson James
$8.00
Buy
934.93%
Upside
Reiterated
05/04/23
Citius Pharmaceuticals (CTXR) PT Lowered to $8 at Dawson JamesDawson James analyst Jason Kolbert lowered the price target on Citius Pharmaceuticals (NASDAQ: CTXR) to $8.00 (from $10.00) while maintaining a Buy rating.
Best Analysts Covering Citius Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy CTXR and Sell After:
1 Month
3 Months
1 Year
Success Rate
10/24 ratings generated profit
Average Return
+4.95%
reiterated a buy rating 7 months ago
Copying Jason Kolbert's trades and holding each position for 1 Year would result in 41.67% of your transactions generating a profit, with an average return of +4.95% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
CTXR Stock Forecast FAQ
What is CTXR’s average 12-month price target, according to analysts?
Currently, no data Available
What is CTXR’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CTXR, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CTXR a Buy, Sell or Hold?
Currently, no data Available
What is Citius Pharmaceuticals’s price target?
Currently, no data Available
What do analysts say about Citius Pharmaceuticals?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of CTXR?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.